OBBI benefits from the strong support of national and regional initiatives dedicated to accelerating innovation in biotherapies. The platform is funded in part through the France 2030 programme, with additional support from the PUI (Pôle Universitaire d’Innovation) of the University of Montpellier and the CeBBOc (Défi clé Biothérapies en Occitanie). This financial backing enables OBBI to advance its organoid and extracellular vesicle technologies and foster impactful collaborations across the academic, clinical, and industrial sectors.